Background/Aims: Obesity is characterized by the immune activation that eventually dampens insulin sensitivity and changes metabolism. This study explores the impact of different inflammatory/ anti-inflammatory paradigms on the expression of toll-like receptors (TLR) found in adipocyte cultures, adipose tissue, and blood. Methods: We evaluated by real time PCR the impact of acute surgery stress in vivo (adipose tissue) and macrophages (MCM) in vitro (adipocytes). Weight loss was chosen as an anti-inflammatory model, so TLR were analyzed in fat samples collected before and after bariatric surgery-induced weight loss. Associations with inflammatory and metabolic parameters were analyzed in non-obese and obese subjects, in parallel with gene expression measures taken in blood and isolated adipocytes/ stromal-vascular cells (SVC). Treatments with an agonist of TLR3 were conducted in human adipocyte cultures under normal conditions and upon conditions that simulated the chronic low-grade inflammatory state of obesity. Results: Surgery stress raised TLR1 and TLR8 in subcutaneous (SAT), and TLR2 in SAT and visceral (VAT) adipose tissue, while decreasing VAT TLR3 and TLR4. MCM led to increased TLR2 and diminished TLR3, TLR4, and TLR5 expressions in human adipocytes. The anti-inflammatory impact of weight loss was concomitant with decreased TLR1, TLR3, and TLR8 in SAT. Cross-sectional associations confirmed increased V/ SAT TLR1 and TLR8, and decreased TLR3 in obese patients, as compared with non-obese subjects. As expected, TLR were predominant in SVC and adipocyte precursor cells, even though expression of all of them but TLR8 (very low levels) was also found in ex vivo isolated and in vitro differentiated adipocytes. Among SVC, CD14+ macrophages showed increased TLR1, TLR2, and TLR7, but decreased TLR3 mRNA. The opposite patterns shown for TLR2 and TLR3 in V/ SAT, SVC, and inflamed adipocytes were observed in blood as well, being TLR3 more likely linked to lymphocyte instead of neutrophil counts. On the other hand, decreased TLR3 in adipocytes challenged with MCM dampened lipogenesis and the inflammatory response to Poly(I:C). Conclusion: Functional variations in the expression of TLR found in blood and hypertrophied fat depots, namely decreased TLR3 in lymphocytes and inflamed adipocytes, are linked to metabolic inflammation.
Introduction
Toll-like receptors (TLR) are evolutionarily conserved receptors that play a key role in the innate immune response to invading pathogens, by sensing either microorganism or danger signals [1] . TLR are also related to non-infectious inflammatory conditions, such as obesity and the initiation and maintenance of innate immune responses conducted in obese adipose tissue (AT) [2, 3] . In fact, the obesity-related frame of low-grade inflammation is often observed in metabolic diseases, and is believed to be due to the increased gut permeability and the impact of structural motifs released by microbial pathogens that may activate TLR found in circulation [4] [5] [6] and AT depots [7] . Thereby, specific cargo of different TLR found in blood immune cells and adipocytes may change peripheral metabolism, responding to different pathogen associated molecular patterns and promoting the shift from anabolic to catabolic processes aimed at providing with energy the immune system [8, 9] .
Signaling by TLR results in a large variety of cellular responses including (but not limited to) the production of cytokines and chemokines responsible of the inflammatory reaction and immune attack against infection [10] . Stimulation of TLR by the corresponding molecular motifs initiates signaling cascades leading to the activation of transcription factors and other molecules involved in inflammation [11] . Overall, TLR activate adapter proteins that lead to NFκB signaling after the formation of IL-1R-associated kinase (IRAK)-1, IRAK-4, tumor necrosis factor associated factor (TRAF)-6, and IκB complexes [12] . TLR1 is an important paralog of TLR6 that shows heterodimerization with TLR2 and the transmembrane signaling receptor activity that mediates innate immune responses to bacterial lipopeptides, leading to the inflammatory reaction, NFκB activation, and cytokine secretion [13] . TLR2 is essential for recognition of Gram-positive bacteria through detection of bacterial lipoproteins, lipomannans and lipoteichoic acids [14] , and has been reported as closely associated with insulin resistance and β-cell dysfunction [15, 16] , including the overexpression found in AT and peripheral blood mononuclear cells from obese and diabetic patients, together with TLR4 [17] . TLR3 is implicated in virus-derived doublestranded RNA, is highly expressed in pancreatic β-cells, and has been functionally related to metabolic inflammation and impaired glucose tolerance through a TLR3 knock-out mice model [18] . Also TLR4, being predominantly activated by lipopolysaccharide [19] , may be linked to the negative impact of elevated levels of free fatty acids and the activation of the immunometabolic regulatory capacity of pathogen-sensing systems downstream NFκB under non-pathological circumstances [20, 21] , leading to metabolic inflammation [22] . Endorsing this observation, TLR4-deficient mice showed protection against diet-induced obesity and insulin resistance [23] , while polymorphisms affecting human TLR4 have been linked to the risk of type 2 diabetes [24] . On their side, TLR5 detects bacterial flagellin [25] , dimers of TLR6 and TLR2 or TLR4 are required for conducting the response to lipoproteins during metabolic endotoxemia [26] , TLR9 is important for the recognition of unmethylated CpG DNA [27] , and TLR7 and TLR8 can intercept single and short double-stranded RNA molecules released within the endosomal compartments [25] , being mostly responsible for the proinflammatory cytokines that are secreted by activated monocytes and lymphocytes [28, 29] . In consensus with such inflammatory signatures and immune activation, elevated AT expression of TLR8 has been also reported in metabolically compromised subjects [30] . Finally, TLR10 has been considered the only orphan human TLR, with no confirmed ligand nor biological function until the findings of Song Jiang and coworkers, supporting the idea that TLR10 may display some anti-inflammatory properties [31] , and the approach recently performed in human AT by Syndhu et al. [32] , suggestive of a relationship with metabolic inflammation.
Over the last years, the constant flow of clinical and experimental data has provided insights pointing at the interrelationship between enlarged fat depots, activated innate immunity, enhanced inflammation, impaired metabolism, systemic insulin resistance, and increased risk of type 2 diabetes in obese patients [33] . However, the immunometabolic capacity of pathogen-sensing systems activated in obesity is still not fully understood [13, 34] . Here, we have conducted four association studies trying to identify variations in TLR gene expression that may alter risk of disease in obese patients. We first looked for TLR that were differentially expressed in the AT of morbid obese patients following surgeryinduced weight loss [35] . From an initial list of ten TLR, we focused on receptors that showed significant modulation after the anti-inflammatory effects of weight loss (i.e. TLR1-8). Then, we explored the effects of different inflammatory paradigms on the expression patterns of subcutaneous and visceral AT and whole blood. Among the former, we evaluated the effects of macrophage conditioned media in vitro (human adipocyte cultures) and acute surgery stress in vivo (human AT). We also assessed the associations of TLR with inflammatory parameters, expression measures taken in blood, and changes identified in ex vivo isolated adipocytes/ stromal-vascular cells. We report here decreased TLR3 in obese AT, blood and inflamed adipocytes, in parallel with immune and inflammatory cues that may impair metabolism in differentiated adipocytes, as further demonstrated by treatments with TLR3 agonists.
Materials and Methods

Subject recruitment
Selection of toll-like receptor (TLR) candidates was performed based on available transcriptomic profiling aimed at identify genes differentially expressed in human adipose tissue after weight loss. The study is described in detail elsewhere [35] . We focused our research on TLR that reported significant variations in this anti-inflammatory model (i.e. TLR1-8, Fig. 1A ). Next, we explored the effects of different inflammatory paradigms on the expression patterns of subcutaneous (SAT) and visceral (VAT) adipose tissue and whole blood. Among the former, we evaluated the impact on TLR expression of acute surgery stress in vivo. Thereby, pre-post paired samples of SAT and VAT were obtained from 32 morbid obese women (body mass index (BMI)=46.4 ± 5.6 kg/m 2 , age=48 ± 10 years [mean ± SD]) following elective surgical procedures at the Department of General, Bariatric and Metabolic Surgery of the Hospital Universitari de la Vall d'Hebron (Barcelona, Spain), as previously explained [36] . We also evaluated cross-sectional associations of SAT and VAT TLR mRNAs with anthropometric, metabolic, immune, and inflammatory parameters in the hallmark of obesity-regulated genes in an extended sample of 80 subjects (28% men, BMI=38.9 ± 7.3 kg/m 2 , age=47 ± 12 years) recruited at the Department of Diabetes, Endocrinology and Nutrition (UDEN), and the Department of Surgery of the Hospital of Girona "Dr Josep Trueta" (Girona, Spain). In parallel, 5 ml of whole blood from 72 independent donors (27% men, BMI=38.8 ± 11 kg/m 2 , age=47 ± 10 years) were collected in PAXgene Blood RNA tubes (Qiagen, Hilden, Germany). The routine blood collection procedures were performed by a nurse of the Hospital of Girona "Dr Josep Trueta", after the research subject information and consent form was reviewed and approved by the corresponding committees. Samples and data from patients included in this study were partially provided by the FATBANK platform, promoted by the CIBEROBN, coordinated by the IDIBGI Biobank (Biobanc IDIBGI, B.0000872) and integrated in the Spanish National Biobanks Network, and were processed following standard operating procedures, including the appropriate approval of the Ethics, External Scientific and FATBANK Internal Scientific Committees. All participants were of Caucasian Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry origin, were free of any infections in the previous month and reported that their body weight has been stable for at least three months before entering the study. No systemic diseases other than type 2 diabetes (35% of participants) and obesity were reported. Liver and thyroid dysfunction were specifically excluded by biochemical work-up. Other exclusion criteria included 1) clinically significant hepatic, neurological, or other major systemic disease, including malignancy, 2) history of drug or alcohol abuse, or serum transaminase activity more than twice the upper limit of normal, 3) an elevated serum creatinine concentration, 4) acute major cardiovascular event in the previous 6 months, 5) acute illnesses and current evidence of high grade chronic inflammatory or infective diseases, and 6) mental illness rendering the subjects unable to understand the nature, scope, and potential consequences of this study. We certify that all institutional regulations concerning the ethical use of information and samples from human subjects were followed during this research.
Clinical measurements
Body mass index (BMI) was calculated as weight (in kilograms) divided by height (in meters) squared. Percent fat mass was measured using the Tanita BIA scale (Tanita Corporation, Tokyo, Japan). Blood samples were drawn after an overnight fasting between 8:00 and 9:00 a.m. Glucose was measured with a glucose oxidase method using a Beckman Glucose Analyzer 2 (Beckman Instruments, Brea, CA). Lipid profile (triglycerides, total cholesterol, and high-density lipoprotein cholesterol (HDL) were measured by usual enzymatic methods on a Hitachi 917 instrument (Roche, Mannheim, Germany). HbA1c was measured by the NGT  NGT  NGT  NGT  NGT  NGT  NGT  T2D  T2D  T2D  T2D  T2D  T2D  T2D  NGT  NGT  NGT  NGT  NGT  NGT  NGT  NGT  NGT  T2D  T2D  T2D  T2D  T2D  T2D high-performance liquid chromatography method (Bio-Rad, Muenchen, Germany). Intra-assay and interassay coefficients of variation were less than 4% for all these tests.
Analyses in isolated AT cell fractions and experiments in vitro
For analyses in isolated stoma-vascular cells (SVC) and mature adipocytes, ~5 g of VAT and SAT from 32 obese women (BMI=43.2 ± 6.3 kg/m 2 , age=45 ± 7 years [mean ± SD]) were isolated and all visible connective tissue was removed. Finely minced samples went through a process of 1 h digestion at 37°C in a shaking water bath. The digestion buffer included 100 mM HEPES containing 120 mM NaCl, 50 mM KCl, 5 mM D-glucose, 1 mM CaCl2, 1.5% type-V bovine serum albumin, 2% penicillin/streptomycin (Sigma Aldrich, St. Louis, MO), and 0.075% (1.5 mg/ml) of Collagenase Type I solution (Worthington Biochemical Corp, Lakewood, NJ). The remaining procedures were similar to the previously described methods [37] . Upon disaggregation, digested AT tissue was centrifuged and cell fractions were collected in 20 ml of PBS 2% penicillin/ streptomycin. Then, cells were passed through sterile nylon mesh filters to remove any remaining tissue debris. Isolated SVC and adipocytes were centrifuged for 1 min at 400 g and water was withdrawn. CD14+ macrophages were isolated from other SVC in a subsample of 6 fat cell debris (3 from VAT and 3 from SAT depots) by means of magnetic cell isolation technology, according to the manufacturer's instructions (Miltenyi Biotec, Madrid, Spain). Cells and fat samples were stored at -80°C until the subsequent analysis.
The human monocyte cell line THP-1 (ATCC, LGC Standards, Barcelona, Spain) was cultured in RPMI 1640 medium containing 10% fetal bovine serum, 5 mM glucose, 2 mM L-glutamine, 50 mg/ml Gentamicin and 20 mM HEPES at 37ºC in a humidified 5% CO 2 / 95ºC air atmosphere, as previously detailed [38] . The mature type 1 macrophage-like state was induced by 24 h of treatment with 0.162 mM phorbol 12-myristate 13-acetate (PMA, Sigma Chemical Co., St. Louis, MO). Differentiated plastic-adherent cells were washed with Dulbecco's phosphate-buffered saline solution (Sigma) and incubated with fresh medium without PMA. Then, differentiated M1 macrophages were incubated for 24 h in medium containing 10 ng/ml of lipopolysaccharide (LPS, Sigma). The LPS-stimulated macrophage conditioned media (MCM) was collected and centrifuged at 400 g for 5 min, and diluted with adipocyte medium (ZenBio, Inc., Research Triangle Park, NC) to provide in adipocytes conditions aimed at simulate the chronic low-grade inflammatory state of obesity [35] .
Human subcutaneous preadipocytes from a Caucasian male with BMI <30 kg/m 2 and age <40 y (ZenBio, Research Triangle Park, NC) were cultured with the preadipocytes medium in a humidified 37ºC incubator with 5% CO 2 . Twenty-four hours after plating, cells were checked for complete confluence and differentiated using differentiation medium following manufacturer's instructions. Two weeks after the initiation of differentiation cells appeared rounded with large lipid droplets apparent in the cytoplasm, were considered differentiated mature adipocytes and were incubated with fresh adipocytes media as control, or fresh adipocytes media containing 2% of MCM. After 24 h of treatment cells were harvested and stored at -80ºC for future analysis. The synthetic double-stranded RNA analog Poly(I:C) (Bio-Techne Europe Ltd., Abingdon, UK) was added to the media (20 µg/ml, 6 h of treatment) in differentiated human adipocytes under normal conditions and after the MCM-induced inflammatory state of activation.
RNA extraction and gene expression measures
Total RNA was purified from blood, AT samples, and cell debris using miRNeasy® Mini Kit (QIAgen, Gaithersburg, MD). AT (~150 µg) and cells were homogenized in 0.6 ml of QIAzol® Lysis Reagent (QIAgen). After addition of chloroform (0.4 volumes), the homogenate was separated into aqueous and organic phases by centrifugation (15 min at 12, 000 g and 4ºC). Then, the upper aqueous RNA-rich phase was isolated and ethanol absolute (1.5 volumes) was added to provide appropriate binding conditions for RNA molecules. The sample was applied to the RNeasy® Mini spin column (QIAgen), where RNA binds to the membrane while phenols and other compounds are washed away. High quality RNA was finally eluted in 30 μl of RNAsefree water. RNA concentrations were assessed with a Nanodrop ND-1000 Spectrophotometer (Thermo Fischer Scientific, Wilmington, DE). The integrity was checked with the Nano lab-on-a-chip assay for total eukaryotic RNA using Bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA). Three μg of RNA were reverse transcribed to cDNA using High Capacity cDNA® Archive Kit, according to the manufacturers' protocol (Applied Biosystems, Darmstadt, Germany). Commercially available and pre-validated TaqMan® primer/ probe sets were used for gene expression determinations (Applied Biosystems), which were assessed by real time PCR using the LightCycler® 480 Real-Time PCR System (Roche Diagnostics, Barcelona, Spain), and , so gene expression results are expressed as expression ratio relative to this preselected and validated housekeeping. Replicates and positive and negative controls were included.
Statistical methods
Descriptive results of continuous variables are expressed as mean ± standard deviation (in vivo assessment) or mean ± standard error (in vitro measures). Before statistical analysis, normal distribution and homogeneity of variances were evaluated using Levene's test. ANOVA, Student's, or paired t-tests were performed to study differences on quantitative variables. The semi-quantitative expression of different TLR was correlated (Pearson's and/or Spearman's tests) with clinical parameters and the expression of other genes in human AT and blood. Statistical analyses were performed with the SPSS statistical software (SPSS V12.0, Inc., Chicago, IL).
Results
Changes in AT TLR expression patterns during inflammation
Wide transcriptomic profiling of abdominal subcutaneous adipose tissue (SAT) before and after weight loss [35] showed significant changes in 7 out of 10 toll-like receptors (TLR). Microarray measures pointed at TLR1 (-44%), TLR2 (-36%), TLR5 (-35%), TLR6 (-34%), TLR7 (-47%), and TLR8 (-53%) as the most significantly (adjusted p-value<0.01) decreased TLR in human SAT upon weight loss (Fig. 1A) . Slightly decreased TLR3 (-12%, adj. p-value=0.046) was also identified, while AT TLR4 (adj. p-value=0.07), TLR9 and TLR10 failed in showing significant modulation upon bariatric surgery. Next, we investigated dynamic adaptations accounting during acute surgical stress in TLR showing significant modulation after weight loss. We tested the impact of acute surgical innate immune system activation leading to inflammation (i.e. increased expressions of IL-6, IL-8, TNF and LBP in fat depots [36] ). The results supported distinct reactions in relation to surgical stress, confirming inflammatory mechanisms leading to changes in human TLR, as inferred by gene expression results in SAT and visceral (VAT) adipose tissue (Table 1 ). Increased TLR2 (1.6-fold, p=0.044, and 2.1-fold change, p=0.003, in SAT and VAT, respectively), and TLR1 (1.2-fold, p=0.047), TLR4 (1.2-fold, p=0.002), and TLR8 (1.3-fold, p=0.009, only in SAT) mRNA was identified, while TLR3 decreased in VAT depots of patients following gastric bypass (-23%, p<0.0001, Table 1 ). Given the changes identified in AT TLR expression upon weight loss and acute inflammation, we hypothesized that adipocyte-specific TLR could influence the local inflammatory milieu by promoting variations in their response. We used an in vitro model of differentiated human adipocytes treated with macrophage lipopolysaccharide (LPS)-conditioned media (MCM, 2%), mimicking the conditions found in hyperplastic AT depots, including overexpression of proinflammatory cytokines and decreased adipocytes performance [35, 38] . We measured the mRNA levels of TLR candidates in this model and in non-differentiated adipocyte precursor cells. Notably, TLR8 mRNA was detectable neither in adipocytes nor in preadipocytes, while the rest of TLR candidates showed decreased expression levels in mature lipid-containing adipocytes, when compared to non-differentiated precursor cells (Fig. 2) . In partial agreement with changes observed upon acute surgical stress, MCM rescued to some extent decreased TLR2 in mature adipocytes, while further diminishing TLR3, TLR4, and TLR5 in differentiated (but not in non-differentiated) adipocytes (Table 1) . Noteworthy, LPS raised the expression of both TLR2 and TLR3 in differentiated THP-1 macrophages (Table 1) . Also of interest, TLR2 and TLR3 in activated macrophages and precursor fat cells were in parallel to -6) , and in association with decreased insulin receptor substrate 1 (IRS1), glucose transporter 4 (GLUT4), and adiponectin (ADIPOQ) in mature adipocytes (Table 1) . Finally, treatments aimed at endorsing the functional relevance of decreased TLR3 in differentiated adipocytes upon inflammation indicated that the response to the synthetic double-stranded RNA analog Poly(I:C) was significantly lower in MCM-activated cells (Fig. 3) . Currently, decreased response to this specific agonist of TLR3 included not only changes affecting the inflammatory profile (i.e. lower expression of IL-6, TNFα, or LBP) but also the lack (AQP9) or even the inversion (FASN, ELOVL6) of metabolic features in mature adipocytes responding to TLR3 agonist, including variations affecting lipolysis and lipogenesis (Fig. 3) . 
AT TLR expression patterns associate with clinical and inflammatory outputs
We validated microarray results using real time PCR in an extended sample of 22 obese women in whom weight loss led to significantly decreased TLR1 (-51%, p<0.0001), TLR3 (-18%, p=0.01), and TLR8 (-65%, p<0.0001), running in parallel to dampened systemic inflammation (decreased blood leukocyte count and TNFα and IL-6 mRNA) and improved glucose and lipid metabolism, as shown by levels of fasting glucose, fasting triglycerides, HDL-cholesterol, and the expression of genes codifying for IRS1, GLUT4 and ADIPOQ ( Table 2) . As a further confirmation of these results, the expression of preselected TLR was quantified in SAT and VAT samples from 80 participants, including the obese patients included in our longitudinal study. Anthropometric, biochemical and gene expression results of participants are summarized in Table 3 . The validation analysis shortlisted five TLR that differed significantly between morbid obese (BMI≥40 kg/m 2 ) patients with or without type 2 diabetes (T2D), and sex and age-matched controls with BMI<30 kg/m 2 and normal glucose tolerance (NGT). In agreement with longitudinal results, TLR1 (58%, p=0.002, and 28%, p=0.015) and TLR8 (57%, p=0.003, and 32%, p=0.026) were increased in SAT and VAT of obese individuals, respectively. In contrast, TLR3 show decreased expression in SAT (but not in VAT) of obese and diabetic participants, when compared to lean and obese subjects with NGT (Table 3) . In this extended sample we also identified significant differences regarding SAT TLR5 and TLR6 (decreased in obese and T2D participants), and VAT TLR5, TLR7 (increased in obese subjects with NGT), and TLR6 (decreased in T2D patients when compared to sex, age, and weight-matched subjects). In partial agreement with previous data [3] , we found a sustained increase of TLR1, TLR3, TLR5, and TLR7 in VAT, when compared to paired SAT samples from obese patients, but not in non-obese participants (Table 3) . Accompanying group-related differences, SAT and VAT TLR1 (p=0.013 and p=0.004), TLR5 (p=0.025 and p=0.046), TLR7 (p=0.049 and p=0.02), and TLR8 (p=0.022, only in SAT) were related to BMI (Table 4) , and single correlations disclosed the positive association with pro-inflammatory genes such as TNFα (TLR1, TLR4, and TLR7) and IL-6 (TLR2, and TLR6) in SAT, and TLR1, TLR2, TLR6, and TLR8 in VAT (Table 4) . Noteworthy, in both depots TLR4 was associated with ADIPOQ and TNFα, pointing out its relationship with macrophages and the inflammatory/ metabolic state of differentiated adipocytes, while SAT TLR3 correlated with white blood Table 4 ). Regarding isolated AT cell fractions, stromal-vascular cells (SVC) were mainly responsible for TLR expressed in SAT and VAT, with minor differences between the TLR members analysed (Fig. 2) . Noteworthy, the analysis of SVC sub-fractions indicated that the expression of TLR1 (2.4-fold, p=0.024), TLR2 (3.8-fold, p<0.0001), and TLR7 (3.9-fold change, p=0.002) was increased in CD14+ cells, mostly composed of macrophages, while TLR3 mRNA was substantially lower in CD14+ cells (-70%, p=0.001) than in the rest of cells found in SVC fractions (data not shown). Among all TLR, the relatively low expression of TLR8 in both SVC and mature adipocytes from SAT and VAT depots was of particular interest. It should be also noted that all TLR results (but TLR3) ran in parallel to the expression levels of TNFα (27-fold and 9-fold change in SAT and VAT, respectively) and the macrophage-specific expression of lysozyme (LYZ, also known as muramidase or N-acetylmuramide glycanhydrolase, with 13-fold and 7-fold change in SVCs when compared to adipocytes from the same sample), while the mRNA of the adipocyte marker ADIPOQ was diminished in SVC, when compared to the depot-specific adipocyte fraction (-98 and -99% in SAT and VAT, respectively, p-values <0.0001 for all comparisons, data not shown).
TLR expression patterns in blood
Previous studies have pointed at the use of blood cells (namely monocytes/ macrophages, B and T lymphocytes, and natural killer cells) as a model to study inflammatory issues and systemic energy homeostasis disturbances [39] [40] [41] . Here, we sought analyze additional associations between TLR expressed in peripheral blood, which may be in line with previous observations in whole blood RNA as a marker for genomic changes in other tissues [42, 43] . In this independent sample of 72 participants, total leukocyte, neutrophil, and monocyte counts were increased in obese subjects, being total leukocytes count significantly associated with insulin resistance. Only TLR8 mRNA in blood cells was significantly associated with both BMI (r=0.26, p=0.028) and metabolic impairment (Table 5 ), being this relationship mostly due to the link between increased neutrophil number and weight. Interestingly, expressions of almost all TLR (TLR4, TLR5, TLR6, and TLR8) were positively related to neutrophils but inversely associated with lymphocyte counts (TLR2, TLR4, and TLR6, Table  5 ). In blood samples, as well as in human AT, only TLR3 showed opposite patters with respect to the association with white blood cells, being positively linked to lymphocytes instead of neutrophils count (Table 5) . 
Discussion
Fighting against infection requires high energy turnover. Thereby, cells those are able to free energy to immunological utilization upon infection and tissue recovering need to be very sensitive to damage and pathogenassociated molecular patterns. In this context, emerging evidences endorse the notion that immune and metabolic systems are highly integrated. Indeed, the increase of activated immune cells in obese subcutaneous (SAT) and visceral (VAT) adipose tissue is accompanied by important changes in adipocyte behavior [38, 44] , modifying the differentiation state and expression and secretion of adipokines that, in turn, may regulate metabolism in AT and many other peripheral tissues [45] . Thus, innate immune pattern recognition receptors and tolllike receptors (TLR)-mediated signaling pathways act as direct sensors for cellular activation, leading to important changes in glucose and lipid homeostasis [46] . Humans possess 10 toll-like receptor (TLR) family members. TLR1, 2, 4, 5, and 6 traffic to the plasma membrane, sense microbial cell components and pathogen-associated molecular patterns, and stimulate the production of proinflammatory molecules. TLRs 3, 7, 8, and 9 are located in endosomal compartments, intercept viral and bacterial nucleic acids, and are best known for their ability to stimulate the production of type 1 interferons [47] . The present study shows concomitant changes affecting the expression levels of TLR found in obese AT and being modified upon surgeryinduced inflammation and weight loss. Current observations point out the activated state of adipocytes and infiltrating immune cells found in AT, being intimately associated with the degree of obesity, inflammation, and metabolic impairment. 
Stress-induced inflammation promotes the shift of TLR expressed by adipocytes
Inflammation caused by the presence and activation of infiltrating immune cells is preceded by white blood cells relocation [48, 49] , paving the way for the recruitment of macrophages and the inflammatory state of activation of mature adipocytes [50] . Here, we found decreased TLR3 gene expression levels accompanying increased TLR2 in obese/ inflamed mature adipocytes. The opposite expression pattern identified for TLR3 and TLR2 was endorsed by i) decreased TLR3 but increased TLR2 gene expression in VAT during acute surgical inflammation, ii) the negative response of TLR3 to the macrophage-conditioned (Fig. 1B, according to the microarray results of reference [51] ), iii) the decreased expression levels found for SAT TLR3 in obese individuals with and without type 2 diabetes (T2D), as compared with lean counterparts with normal glucose tolerance, and iv) the positive association of TLR2 with inflammation and decreased glucose tolerance (Fig. 4) . Current results validate the synergistic impact of obesity-related inflammation and decreased glucose intake on TLR2, being positively associated with physiological variations such as leukocyte/ neutrophil numbers, inflammatory activation of fat cells, and fasting glycemia following weight loss [52, 53] , while TLR3 in mature adipocytes responded negatively to the inflammatory stimuli. Interestingly, among the significant values of correlation found in AT, the coatomer protein complex subunit alpha (COPA) and the solute carrier family 11 member 2 (SLC11A2, also known as natural resistance-associated macrophage protein 2, or NRAMP2) showed positive correlation with TLR2, while the leptin receptor (LEPR) was associated with TLR3 gene expression in human AT (Table 6 and Fig. 5 ). Of note, COPA proteins are involved in the regulation of lipid droplet formation by establishing connections with the endoplasmic 
Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry reticulum, allowing delocalization of enzymes involved in triacylglycerol metabolism [54, 55] . On the other hand, SLC11A2 participates in the regulation of cellular iron metabolism [56] , leading to the proper functioning and activation of AT macrophages [57] . Regarding AT/ adipocytes TLR3, the association of LEPR points out important insights into regulatory mechanisms leading to inflammation, metabolism and immune disorders conducted through changes in fat cells [58] . In line with this, Strodthoff et al. [18] provided evidence showing that TLR3 regulates glucose metabolism though the modulation of insulin levels but not by changes in weight or peripheral insulin sensitivity. To determine whether TLR3 is linked to metabolic inflammation beyond fatty acids and glucose modulation of other TLR, these authors investigated physiological changes in Tlr3 -/-mice and the impact of genetic variants affecting TLR3 and insulin-related traits. They concluded that the absence of functional TLR3 "protects" against metabolic disturbances due to changes in fat intake and lipid metabolism, in spite of the systemic inflammation found in Tlr3 -/-mice [18] . On the other hand, Poly(I:C) enhanced the differentiation of in vitro cultured mesenchymal stem cells towards lipidcontaining mature adipocytes [59] . Current dissection of tissue-specific obesity-related inflammation and insulin resistance in human AT shows decreased TLR3 in adipocytes, which is linked to decreased leptin receptor in obese/ inflamed states that may influence glucose homeostasis and fatty acid metabolism, as further demonstrated by treatments with agonists of TLR3. Thereby, decreased TLR3 in obese adipocytes may disrupt the response to double-stranded RNA and the synthesis of molecules that are involved in the regulation and maintenance of the differentiation state, together with the immunosuppressive capacity of mature adipocytes and precursor stem cells [60] .
Dynamic changes in TLR are related to cell type and the activation state
Although tissue and blood-based transcriptomics research has great potential in clinical applications, it has its own set of limitations. For instance, whole blood and tissue sampling introduces cell distribution and variations in cell population. Thus, the dynamic composition of heterogenic samples in response to environmental fluctuations or disease may exhibit some degree of variability not representative for molecular changes in cells itself. Endorsement of results from different experimental designs and samples may overlap this handicap. Thereby, while specific features of inter-individual variation in gene expression patterns could be traced to variation in percent of cell subsets [42, 61] , other features may be related to changes in metabolism and the state of activation of specific cells [44] . Fat depots are in a constant flux with changing cellular populations. Obesity can tip the scale towards the accumulation of certain cell populations and the dysregulation of others. For example, circulating immune cells such as macrophages, lymphocytes, and neutrophils are found composing the stromal-vascular cell (SVC) fraction [62] , and are believed to promote the local inflammation and deleterious consequences of an hyperplastic AT [44] . In obesity, Plots showing correlation between TLR2 and TLR3 mRNA and the expression levels assessed for other coding and non-coding RNAs measured by microarray in human adipose tissue of 16 women at the baseline (PRE) and ~2-years after gastric bypass (POST) [35] . COPA: coatomer protein complex subunit alpha, SLC11A2: solute carrier family 11 member 2, LEPR: leptin receptor. AT macrophages content increases from 10-15% to 50-60% of SVC total cells and is higher in visceral than in subcutaneous AT, consistent with the hypothesis that visceral fat plays a more prominent role in insulin resistance and inflammation [63] . In agreement with this, the magnitude of obesity-induced up-regulation of many TLR was greater in visceral than in subcutaneous AT, affecting both diet and genetically-induced obese mice [3] , and being related to weight and the degree of inflammation and metabolic impairment. Precisely, the dynamic changes seen in TLR expressed by obese/ inflamed AT of men and mice can be referred to as the AT remodeling during the course of obesity, in which SVC change dramatically in number and cell type, turning into proinflammatory signaling cascades. In this context, changes in the expression of TLR found in human AT, especially during obesity-related chronic immune activation and the surgery-induced acute inflammation reflected by increased TLR1, TLR2 and TLR8, were more likely linked to cells from SVC, and were more prominent in VAT than in SAT, while decreased TLR3 in obese SAT depicted biological variations affecting differentiated adipocytes as the most prevalent cellular specie in this depot. Also of interest, the dynamic changes mirrored by results assessed in different samples indicate the close association of whole blood and AT TLR3 measures with lymphocytes, pointing out a unique feature of this TLR. Trying to endorse this concept, we evaluated Spearman's r and p-values derived from measures of the level of significance in correlations detected between AT TLR gene candidates and microarray expressions values. The computed significant values of correlation at the baseline and after weight loss identified a list of 15 and 28 coding and noncoding transcripts associated with TLR2 and TLR3, respectively (Table 6 ). Here, SAT TLR3 measures correlated with the expression of T cell surface receptors and major lymphocyte specification factors such as FOXP3, TRAV8-1 (inversely), and TRAJ2 (directly associated). Noteworthy, decreases in regulatory T cell population have been previously reported in VAT of genetically obese mice, being opposite to the macrophage number, inflammation, and metabolic impairment [64, 65] .
Conclusion
We confirm significant fluctuations in TLR patterns in human AT, namely visceral TLR1, 2, 3, 5, 7, and 8, which are associated with inflammatory and metabolic issues linked to obese AT. While TLR1 and 8 seem to be linked to the composition of the SVC fraction, specific stress-related changes affecting the expression levels of TLR2 and 3 in adipocytes have been identified in all samples. The observation is in concordance with previous studies demonstrating that increased expression of all TLR but TLR3 is linked to diet-induced obese AT, in close association with inflammation and decreased insulin sensitivity [3] . Thus, beside their defense function of alerting immune system of the presence of microorganisms, TLR being expressed in energy-storage cells such as adipocytes may be of great interest for the understanding of metabolic inflammation and associated diseases. Current data point out the decreased expression of TLR3 in adipocytes at the forefront of changes affecting AT homeostasis in obesity-associated inflammatory states. Obviously, this conclusion needs to be further endorsed in additional follow-up studies including the interplay of strain and race/ethnicity in the innate immune response to the risk of impaired metabolism under conditions that elicit diminished TLR3 in fat cells. However, from a clinical point of view, our results represent new insight regarding the role of TLR regulation in AT for further reinforce the dynamic mechanisms linking inflammation and metabolism, which might reveal future novel therapeutic targets.
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